Celltrion, Inc. Stock OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 41,712B 30.97B 27.52B 25.68B 23.41B 44.15B 2,977B 44.56B 311B 120B 1,522B 116B 114B 4,885B | P/E 2026 * |
27.6x | P/E 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 43.91B 32.6M 28.97M 27.04M 24.64M 46.48M 3.13B 46.91M 327M 127M 1.6B 122M 120M 5.14B | EV / Sales 2026 * |
7.93x | EV / Sales 2027 * | 6.78x |
| Free-Float |
60.59% | Yield 2026 * |
0.41% | Yield 2027 * | 0.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 51 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 69 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 30.77B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -2.32% | +23.28% | +77.03% | 59.26B | |
| +0.89% | -0.77% | +5.80% | +32.89% | 47.14B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.91B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.13B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.79B | |
| -0.54% | +2.93% | +9.50% | +50.41% | 30.77B | |
| -2.68% | +5.11% | +33.11% | +19.50% | 29.31B | |
| +2.33% | -5.69% | -27.28% | +338.00% | 23.71B | |
| Average | +0.02% | -0.64% | +52.89% | +159.49% | 43.6B | |
| Weighted average by Cap. | +0.22% | -0.40% | +58.02% | +150.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,535B 4.11B 3.65B 3.41B 3.11B 5.86B 395B 5.91B 41.24B 15.98B 202B 15.43B 15.1B 648B | 6,350B 4.71B 4.19B 3.91B 3.56B 6.72B 453B 6.78B 47.32B 18.33B 232B 17.7B 17.32B 744B |
| Net income | 1,538B 1.14B 1.01B 947M 863M 1.63B 110B 1.64B 11.46B 4.44B 56.11B 4.29B 4.19B 180B | 1,780B 1.32B 1.17B 1.1B 999M 1.88B 127B 1.9B 13.26B 5.14B 64.95B 4.96B 4.85B 208B |
| Net Debt | 2,198B 1.63B 1.45B 1.35B 1.23B 2.33B 157B 2.35B 16.38B 6.35B 80.19B 6.13B 5.99B 257B | 1,318B 979M 870M 812M 740M 1.4B 94.08B 1.41B 9.82B 3.81B 48.1B 3.67B 3.59B 154B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
